SCHEMBL3401912

SCHEMBL3401912

COc1cc(OC)nc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
L3MBTL1 Q9Y468 2/20 0.52
KDM4E B2RXH2 2/20 0.48
PDE2A O00408 1/20 0.45
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
CYP1A1 P04798 3/20 0.42
CYP1B1 Q16678 3/20 0.42
CA4 P22748 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29452983 0.97 ALDH1A1 (0.53) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL8894323 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL7819657 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL29870734 0.83 NOS3 (0.47) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL9619606 0.83 L3MBTL1 (0.44) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL29506744 0.83 L3MBTL1 (0.44) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL1671268 0.83 L3MBTL1 (0.44) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL2901671 0.83 NOS3 (0.47) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
Hydrochloric Acid SCHEMBL15545578 0.81 NOS1 (0.45) ALDH1A1L3MBTL1KDM4EPDE2ALMNA
SCHEMBL987189 0.81 TDP1 (0.62) ALDH1A1L3MBTL1KDM4ELMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116396209-B Alkyl perfluoroalkyl ketone compound and preparation method thereof 南方科技大学 2025-04-29 CN claimed
CN-118925800-A Acid modified supported COFs catalyst and preparation method and application thereof 浙江工业大学 2024-11-12 CN claimed
CN-116396209-A Alkyl perfluoroalkyl ketone compound and preparation method thereof 南方科技大学 2023-07-07 CN claimed
CN-116396209-B Alkyl perfluoroalkyl ketone compound and preparation method thereof 南方科技大学 2025-04-29 CN disclosed
CN-118925800-A Acid modified supported COFs catalyst and preparation method and application thereof 浙江工业大学 2024-11-12 CN disclosed
CN-116396209-A Alkyl perfluoroalkyl ketone compound and preparation method thereof 南方科技大学 2023-07-07 CN disclosed
US-10611723-B2 Ligand-enabled meta-C-H activation using a transient mediator THE SCRIPPS RESEARCH INSTITUTE (US) 2020-04-07 US disclosed
WO-2016123361-A1 LIGAND-ENABLED META-C-H ACTIVATION USING A TRANSIENT MEDIATOR THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-04 WO disclosed
EP-2500345-B1 8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2015-01-28 EP disclosed
US-8933229-B2 8-azabicyclo[3.2.1]octane-8-carboxamide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2015-01-13 US disclosed
US-8933229-B2 8-azabicyclo[3.2.1]octane-8-carboxamide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2015-01-13 US disclosed
WO-2008020113-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2008-02-21 WO disclosed
US-6656328-B2 Subjecting a polyhydric alcohol compound having protected hydroxy group(s) to microwave irradiation in presence of basic compound or acid to deprotect the protecting groups of hydroxy group of polyhydric alcohol compound NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2003-12-02 US disclosed
EP-1298115-A1 PROCESS FOR THE PREPARATION OF POLYHYDRIC ALCOHOLS National Institute of Advanced Industrial Science and Technology (JP) 2003-04-02 EP disclosed
US-20020157939-A1 Process for preparation of polyhydric alcohols NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2002-10-31 US disclosed
US-5656648-A TREATMENT OF PATHOLOGIES NECESSITATING STIMULATION OF CHOLECYSTOKININ-A RECEPTORS BY TOTAL OR PARTIAL AGONIST EFFECT SANOFI (FR) 1997-08-12 US disclosed
EP-0611766-A1 Polysubstituted 2-amido thiazoles derivatives, process for their preparation, pharmaceutical compositions and utilization for the preparation of a medicament SANOFI (FR) 1994-08-24 EP disclosed
EP-0104876-B1 HERBICIDAL CYCLOHEXANE-1,3-DIONE DERIVATIVES ICI AUSTRALIA LIMITED (AU) 1991-12-27 EP disclosed
US-4631081-A Herbicidal cyclohexane-1,3-dione derivatives ICI AUSTRALIA LIMITED (AU) 1986-12-23 US disclosed
EP-0104876-A2 Herbicidal cyclohexane-1,3-dione derivatives ICI AUSTRALIA LIMITED (AU) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10611723-B2 Ligand-enabled meta-C-H activation using a transient mediator HRH4, AHR, HRH3 ALDH1A1 2756/4885L3MBTL1 2250/4885KDM4E 3368/4885
US-20020157939-A1 Process for preparation of polyhydric alcohols ADH1C, ADH1A, ADH5 ALDH1A1 315/4885L3MBTL1 4550/4885KDM4E 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.